Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F, Henze G, Jürgens H, Kabisch H, Havers W, Reiter A, Kluba U, Niggli F, Gadner H. Creutzig U, et al. Among authors: havers w. J Clin Oncol. 2001 May 15;19(10):2705-13. doi: 10.1200/JCO.2001.19.10.2705. J Clin Oncol. 2001. PMID: 11352963 Clinical Trial.
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H. Schrappe M, et al. Among authors: havers w. Klin Padiatr. 1998 Jul-Aug;210(4):192-9. doi: 10.1055/s-2008-1043878. Klin Padiatr. 1998. PMID: 9743952 Clinical Trial.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group. Möricke A, et al. Blood. 2008 May 1;111(9):4477-89. doi: 10.1182/blood-2007-09-112920. Epub 2008 Feb 19. Blood. 2008. PMID: 18285545 Free article. Clinical Trial.
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Göbel U, Havers W, Henze G, Hinderfield L, Höcker P, Jobke A, Jürgens H, Kabisch H, Landbeck G, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wüst G. Winkler K, et al. Among authors: havers w. J Cancer Res Clin Oncol. 1983;106 Suppl:1-7. doi: 10.1007/BF00625042. J Cancer Res Clin Oncol. 1983. PMID: 6193123 Clinical Trial.
Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N, Schüler A, Bechrakis N, Henze G, Havers W. Bornfeld N, et al. Among authors: havers w. Klin Padiatr. 1997 Jul-Aug;209(4):216-21. doi: 10.1055/s-2008-1043953. Klin Padiatr. 1997. PMID: 9293453 Clinical Trial.
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years].
Dörffel W, Albrecht M, Lüders H, Marciniak H, Parwaresch R, Schwarze EW, Trauzeddel R, Havers W, Henze G, Janka-Schaub G, Mann G, Niemeyer C, Pötter R, Schellong G, Selle B, Treuner J, Rühl U. Dörffel W, et al. Among authors: havers w. Klin Padiatr. 1998 Jul-Aug;210(4):212-9. doi: 10.1055/s-2008-1043881. Klin Padiatr. 1998. PMID: 9743955 Clinical Trial. German.
86 results